weight loss program with semaglutide glp-1 ozempic in dana point Diet Plan for Optimal Results Glucagon-like peptide-1 (GLP-1) receptor agonists

Seek medical care for severe symptoms such as persistent vomiting, severe abdominal pain, dehydration, fainting, chest pain, shortness of breath, or confusion

People who developed stomach paralysis, pancreatitis, pancreatic cancer, or other complications may be entitled to compensation in a weight loss drug lawsuit.

A study shows that women who have gone through menopause can lose significantly more weight while taking a combination of semaglutide and hormone therapy.

The class of drugs, which includes Novo Nordisks Ozempic and Wegovy, are associated with the risk of gastrointestinal adverse events when used for weight loss, finds a study published Thursday in JAMA.